Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T71773 |
Levomepromazine Maleate
|
||
Levomepromazine Maleate is a Tricyclic antidepressant (TCA), acting as a serotonin–norepinephrine reuptake inhibitor (SNRI) and also having other activities including antihistamine, antiadrenergic, antiserotonergic, anticholinergic, and sodium channel-blocking effects. | |||
T71160 |
Levomepromazine HCl
|
||
Levomepromazine HCl is a phenothiazine with pharmacological activity similar to that of both CHLORPROMAZINE and PROMETHAZINE. It has the histamine-antagonist properties of the antihistamines together with CENTRAL NERVOUS SYSTEM effects resembling those of chlorpromazine. | |||
T13470 |
(±)-Levomepromazine-d6
dl-Methotrimeprazine D6,(±)-Methotrimeprazine (D6) |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
(±)-Methotrimeprazine (D6) is the deuterium labeled Methotrimeprazine, which is an antagonist of D3 dopamine and Histamine H1 receptor. | |||
T15743 |
Levomepromazine
Methotrimeprazine |
Others | Others |
Methotrimeprazine is an orally available neuroleptic agent. It is commonly used to relieve nausea and vomiting in palliative care settings. Levomepromazine has antagonist actions at multiple neurotransmitter receptor sites, including cholinergic, dopamine |